BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 182 filers reported holding BRIDGEBIO PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,991,277 | +24.8% | 1,023,560 | -18.6% | 0.01% | +50.0% |
| Q2 2023 | $21,632,612 | +62.4% | 1,257,710 | +56.5% | 0.00% | +33.3% |
| Q1 2023 | $13,322,561 | -40.8% | 803,532 | -72.8% | 0.00% | -40.0% |
| Q4 2022 | $22,497,958 | +20.1% | 2,952,488 | +56.6% | 0.01% | +25.0% |
| Q3 2022 | $18,737,000 | +118.8% | 1,885,012 | +99.9% | 0.00% | +100.0% |
| Q2 2022 | $8,562,000 | +52.8% | 942,994 | +70.8% | 0.00% | +100.0% |
| Q1 2022 | $5,604,000 | -58.9% | 552,062 | -32.5% | 0.00% | -66.7% |
| Q4 2021 | $13,642,000 | -39.2% | 817,900 | +71.0% | 0.00% | -25.0% |
| Q3 2021 | $22,420,000 | -28.6% | 478,348 | -7.2% | 0.00% | -42.9% |
| Q2 2021 | $31,417,000 | +75.2% | 515,378 | +77.0% | 0.01% | +75.0% |
| Q1 2021 | $17,936,000 | -15.0% | 291,185 | -1.8% | 0.00% | -20.0% |
| Q4 2020 | $21,090,000 | +337.4% | 296,583 | +130.8% | 0.01% | +400.0% |
| Q3 2020 | $4,822,000 | +117.2% | 128,518 | +88.8% | 0.00% | 0.0% |
| Q2 2020 | $2,220,000 | +15.7% | 68,084 | +2.9% | 0.00% | – |
| Q1 2020 | $1,919,000 | +219.3% | 66,168 | +197.0% | 0.00% | – |
| Q2 2019 | $601,000 | – | 22,281 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $100,609,513 | 48.41% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $514,990,899 | 15.50% |
| M28 Capital Management LP | 304,700 | $5,051,926 | 5.71% |
| Cormorant Asset Management, LP | 4,557,414 | $75,562 | 4.98% |
| Octagon Capital Advisors LP | 1,338,160 | $22,186,693 | 3.19% |
| Ikarian Capital, LLC | 594,686 | $9,859,894 | 2.24% |
| Affinity Asset Advisors, LLC | 389,800 | $6,462,884 | 2.13% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $441,376,031 | 2.07% |
| Ikarian Capital, LLC | 549,600 | $9,112,368 | 2.07% |
| Affinity Asset Advisors, LLC | 320,000 | $5,305,600 | 1.75% |